Anita Burrell

Anita has led teams to success across a wide variety of roles and geographies.  At Sanofi, she headed Global Health Economics, Worldwide Pricing and Reimbursement and was an R&D champion bringing Aubagio, the oral MS therapy, to market ahead of schedule. She has served on the HBA Board of Directors and led the ISPOR Special Interest Group for Digital Health

As a consultant Anita has helped companies to:

•Understand market dynamics and payer behavior across many diseases including immunology, cardiovascular, oncology, hematology and endocrinology in the top 11 markets including Europe, Japan and the US

•Design integrated evidence plans to demonstrate robust demonstration of product benefits for faster market uptake

•Establish credibility for a Global Market Access Insights function through thought leadership, strategic vision and producing three product lines within 9 months

•Understand the Global Evolution of the Biosimilar Market and prepare for the future implications in Europe and the United States

Anita holds a BA (Hons) Economics from the University of Stirling, an M.A. Economics from Dalhousie University, Nova Scotia, Canada, and an MBA from Kingston University, Surrey UK. She speaks French at an advanced level.